Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ENGN | Common Shares | Options Exercise | $107 | +120 | +0.49% | $0.89 | 24.7K | May 28, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ENGN | Stock Option (Right to Buy) | Options Exercise | $0 | -120 | -100% | $0.00* | 0 | May 28, 2024 | Common Shares | 120 | $0.89 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | This option is fully vested and exercisable. |
F2 | This option was originally due to expire December 4, 2023, however prior to that date the expiration date was extended to 120 days following the filing of enGene Holdings Inc.'s Form S-8, which was filed February 27, 2024. Accordingly, the option expiry date is June 26, 2024. |